Vir Biotechnology, Inc. (VIR)
10.88
+0.28
(+2.59%)
USD |
NASDAQ |
Sep 21, 16:00
11.04
+0.16
(+1.52%)
After-Hours: 20:00
Vir Biotechnology Market Cap : 1.840B for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.793B |
| September 17, 2026 | 1.848B |
| September 16, 2026 | 1.780B |
| September 15, 2026 | 1.766B |
| September 14, 2026 | 1.821B |
| September 11, 2026 | 1.797B |
| September 10, 2026 | 1.790B |
| September 09, 2026 | 1.829B |
| September 08, 2026 | 1.891B |
| September 04, 2026 | 1.926B |
| September 03, 2026 | 1.937B |
| September 02, 2026 | 1.946B |
| September 01, 2026 | 1.968B |
| August 31, 2026 | 1.851B |
| August 28, 2026 | 1.832B |
| August 27, 2026 | 1.913B |
| August 26, 2026 | 1.875B |
| August 25, 2026 | 1.812B |
| August 24, 2026 | 1.677B |
| August 21, 2026 | 1.655B |
| August 20, 2026 | 1.558B |
| August 19, 2026 | 1.653B |
| August 18, 2026 | 1.606B |
| August 17, 2026 | 1.589B |
| August 14, 2026 | 1.563B |
| Date | Value |
|---|---|
| August 13, 2026 | 1.523B |
| August 12, 2026 | 1.516B |
| August 11, 2026 | 1.511B |
| August 10, 2026 | 1.504B |
| August 07, 2026 | 1.492B |
| August 06, 2026 | 1.483B |
| August 05, 2026 | 1.541B |
| August 04, 2026 | 1.551B |
| August 03, 2026 | 1.506B |
| July 31, 2026 | 1.396B |
| July 30, 2026 | 1.435B |
| July 29, 2026 | 1.393B |
| July 28, 2026 | 1.427B |
| July 27, 2026 | 1.419B |
| July 24, 2026 | 1.401B |
| July 23, 2026 | 1.506B |
| July 22, 2026 | 1.508B |
| July 21, 2026 | 1.519B |
| July 20, 2026 | 1.488B |
| July 17, 2026 | 1.520B |
| July 16, 2026 | 1.516B |
| July 15, 2026 | 1.549B |
| July 14, 2026 | 1.530B |
| July 13, 2026 | 1.567B |
| July 10, 2026 | 1.606B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Caribou Biosciences, Inc. | 138.32M |
| Arrowhead Pharmaceuticals, Inc. | 9.710B |
| Oncolytics Biotech, Inc. | 95.71M |
| Sangamo Therapeutics, Inc. | 60.03M |
| Sarepta Therapeutics, Inc. | 2.126B |
Market Cap Related Metrics
| PS Ratio | 5.329 |
| Price to Book Value | 1.873 |
| Price | 10.88 |
| Earnings Yield | -17.12% |